參考文獻 |
[1] J. Wei, J. M. Buriak, and G. Siuzdak, "Desorption-ionization mass spectrometry on porous silicon," Nature, vol. 399, pp. 243-246, 1999.
[2] J. J. Thomas, Z. X. Shen, R. Blackledge, and G. Siuzdak, "Desorption-ionization on silicon mass spectrometry: an application in forensics," Analytica Chimica Acta, vol. 442, pp. 183-190, 2001.
[3] K. Huikko, P. Ostman, C. Sauber, F. Mandel, K. Grigoras, S. Franssila, T. Kotiaho, and R. Kostiainen, "Feasibility of atmospheric pressure desorption/ionization on silicon mass spectrometry in analysis of drugs," Rapid Communications in Mass Spectrometry, vol. 17, pp. 1339-1343, 2003.
[4] K. Pihlainen, K. Grigoras, S. Franssila, R. Ketola, T. Kotiaho, and R. Kostiainen, "Analysis of amphetamines and fentanyls by atmospheric pressure desorption/ionization on silicon mass spectrometry and matrix-assisted laser desorption/ionization mass spectrometry and its application to forensic analysis of drug seizures," Journal of Mass Spectrometry, vol. 40, pp. 539-545, 2005.
[5] C. W. Tsao, P. Kumar, J. K. Liu, and L. Devoe, "Dynamic electrowetting on nanofilament silicon for matrix-free laser desorption/ionization mass spectrometry," Analytical Chemistry, vol. 80, pp. 2973-2981, 2008.
[6] J. Sunner, E. Dratz, and Y. C. Chen, "Graphite Surface Assisted Laser Desorption/Ionization Time-of-Flight Mass-Spectrometry of Peptides and Proteins from Liquid Solutions," Analytical Chemistry, vol. 67, pp. 4335-4342, 1995.
[7] C. S. Pan, S. Y. Xu, L. G. Hu, X. Y. Su, J. J. Ou, H. F. Zou, Z. Guo, Y. Zhang, and B. C. Guo, "Using oxidized carbon nanotubes as matrix for analysis of small molecules by MALDI-TOF MS," Journal of the American Society for Mass Spectrometry, vol. 16, pp. 883-892, 2005.
[8] S. A. Trauger, E. P. Go, Z. X. Shen, J. V. Apon, B. J. Compton, E. S. P. Bouvier, M. G. Finn, and G. Siuzdak, "High sensitivity and analyte capture with desorption/ionization mass spectrometry on silylated porous silicon," Analytical Chemistry, vol. 76, pp. 4484-4489, 2004.
[9] Tsao, C.W., et al., Fabrication of nanostructured silicon by metal-assisted etching and its effects on matrix-free laser desorption/ionization mass spectrometry. Analytica Chimica Acta, 2011. 687(2): p. 97-104.
[10] M. E. Davis, "Ordered porous materials for emerging applications," Nature, vol. 417, pp. 813-821, 2002.
[11] M. J. Sailor, "Color me sensitive: Amplification and discrimination in photonic silicon nanostructures," Acs Nano, vol. 1, pp. 248-252, 2007.
[12] E. J. Anglin, L. Y. Cheng, W. R. Freeman, and M. J. Sailor, "Porous silicon in drug delivery devices and materials," Advanced Drug Delivery Reviews, vol. 60, pp. 1266-1277, 2008.
[13] S. P. Low, K. A. Williams, L. T. Canham, and N. H. Voelcker, "Generation of reactive oxygen species from porous silicon microparticles in cell culture medium," Journal of Biomedical Materials Research Part A, vol. 93A, pp. 1124-1131, 2010.
[14] 吳佳頤。薄層層析法和表面輔助雷射脫附/游離飛行時間質譜法的組合應用在紫質的分析,碩士論文,2002, p.21-22。
[15] Bezuidenhout, L.W. and M.J. Brett, Ultrathin layer chromatography on nanostructured thin films. Journal of Chromatography A, 2008. 1183(1-2): p. 179-185.
[16] Olesik, S.V. and J.E. Clark, Technique for Ultrathin Layer Chromatography Using an Electrospun, Nanofibrous Stationary Phase. Analytical Chemistry, 2009. 81(10): p. 4121-4129.
[17] Bakry, R., et al., Monolithic porous polymer layer for the separation of peptides and proteins using thin-layer chromatography coupled with MALDI-TOF-MS. Analytical Chemistry, 2007. 79(2): p. 486-493.
[18] Zhang, L.H., et al., Microchip isoelectric focusing with monolithic immobilized pH gradient materials for proteins separation. Electrophoresis, 2009. 30(23): p. 4034-4039.
[19] Frechet, J.M.J., et al., Monolithic Superhydrophobic Polymer Layer with Photopatterned Virtual Channel for the Separation of Peptides Using Two-Dimensional Thin Layer Chromatography-Desorption Electrospray Ionization Mass Spectrometry. Analytical Chemistry, 2010. 82(6): p. 2520-2528.
[20] Clicq, D., et al., Porous silicon as a stationary phase for shear-driven chromatography. Journal of Chromatography A, 2004. 1032(1-2): p. 185-191.
[21] Gardeniers, J.G.E., et al., Characterization of porous silicon integrated in liquid chromatography chips. Lab on a Chip, 2009. 9(3): p. 456-463.
[22] Tanaka, K., et al., A new rapid and comprehensive peptidome analysis by one-step direct transfer technology for 1-D electrophoresis/MALDI mass spectrometry. Biochemical and Biophysical Research Communications, 2009. 379(1): p. 110-114.
[23] Meatherall, R., GC-MS confirmation of codeine, morphine, 6-acetylmorphine, hydrocodone, hydromorphone, oxycodone, and oxymorphone in urine. Journal of Analytical Toxicology, 1999. 23(3): p. 177-186.
[24] Pragst, F., et al., Detection of 6-acetylmorphine in vitreous humor and cerebrospinal fluid - Comparison with urinary analysis for proving heroin administration in opiate fatalities. Journal of Analytical Toxicology, 1999. 23(3): p. 168-172.
[25] Cingolani, M., et al., Analytical detection and quantitation of strychnine in chemically fixed organ tissues. Journal of Analytical Toxicology, 1999. 23(3): p. 219-221.
[26] http://www.chromacademy.com/resolver-november2010_Understanding_GCMS_part_1.asp
[27] Armbruster, D.A., M.D. Tillman, and L.M. Hubbs, Limit of Detection (Lod) Limit of Quantitation (Loq) - Comparison of the Empirical and the Statistical, Methods Exemplified with Gc-Ms Assays of Abused Drugs. Clinical Chemistry, 1994. 40(7): p. 1233-1238.
[28] Peters, F.T., et al., Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry. Journal of Mass Spectrometry, 2003. 38(6): p. 659-676.
[29] Huestis, M.A., et al., Simultaneous quantification of methamphetamine, cocaine, codeine, and metabolites in skin by positive chemical ionization gas chromatography-mass spectrometry. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences, 2006. 833(2): p. 210-218.
[30] McLafferty, F. W.. Wiley Registry of Mass Spectral Data (9th ed.), 2009
[31] Pfleger, K., Maurer, H. H., & Weber, A. Mass Spectral Libraryof Drugs, Poisons, Pesticides and Their Metabolites. Angilent Technologies. (3rd ed.), 2000.
[32] 陳亭亭, 潘日南,許美智,倪戌江, "濫用藥物的檢驗分析及認證制度",臺灣警察專科學校警專學報,民國98 年4 月, p.35-46
[33] Wohlfarth, A., W. Weinmann, and S. Dresen, LC-MS/MS screening method for designer amphetamines, tryptamines, and piperazines in serum. Analytical and Bioanalytical Chemistry, 2010. 396(7): p. 2403-2414.
[34] Weinmann, W., et al., Determination of basic drugs of abuse in human serum by online extraction and LC-MS/MS. Analytical and Bioanalytical Chemistry, 2009. 395(8): p. 2499-2507.
[35] Queiroz, J.A., E. Gallardo, and M. Barroso, LC-MS: a powerful tool in workplace drug testing. Drug Testing and Analysis, 2009. 1(3-4): p. 109-115.
[36] Maurer, H.H., et al., Drugs of abuse screening in urine as part of a metabolite-based LC-MS(n) screening concept. Analytical and Bioanalytical Chemistry, 2011. 400(10): p. 3481-3489.
[37] http://www.grin.com/en/doc/251158/quantitative-mass-spectrometric-approaches-to-study-the-role-of-protein
[38] 李光輝,馮煥光,林玉財,”安非他命的藥理學”,國防醫學民國八十一年十二月,第5卷第6 期,p.528-530.
[39] J.A.Harvey , “Behavioral pharmacology of central nervous system
stimulants” ,Neuropharmacology ,1987, p.26-286
[40] 蔡維禎,”安非他命中毒”,臨床醫學,民國七十九年,第26 卷第5 期,p.339-343.
[41] N.E.Cray , P. Saiodi , “Methamphetamine intoxication”, Am Journal of Medicine ,1978,64, p.537-539.
[42] R.C.W. Hall , M.K. Popkin , T.P. Beresford , “Amphetamine psychosis clinical presentation and differential diagnosis” , Psychiatric Medicine , 1988 , 6 , p.73.
[43] 行政院衛生署管制藥品管理局, “常見濫用藥物檢驗方法” ,民國九十三年七月,第一版,p.4-162.
[44] M. J.Ellenhorn and D. G.Barceloux, "Medical Toxicology-Diagnosis and Treatment of Human Poisoning", Elsevier,1988, p.698-709
[45] Wasels, R. and F. Belleville, Gas-Chromatographic Mass-Spectrometric Procedures Used for the Identification and Determination of Morphine, Codeine and 6-Monoacetylmorphine. Journal of Chromatography A, 1994. 674(1-2): p. 225-234.
[46] 徐健民編輯,"工作場所藥物檢驗彙編",中央警察大學印行,民國86 年9 月,p.252-261
[47] B.L. Posey, S.N. Kimble,"High-Performance Liquid Chromatographic Study of Codeine,Norcodeine,and Morphine as Indicators of Codeine Ingestion",J Anal Toxicol, 1984, p.8-64
[48] Kronstrand, R., et al., Codeine concentration in hair after oral administration is dependent on melanin content. Clinical Chemistry, 1999. 45(9): p. 1485-1494.
[49] Stanley V, Hunt J, Willis KW, Stephen CR. Cardiovascular and respiratory function with CI-581. Anesth Analg 1968; 47(6): p.760-768.
[50] Domino EF, Chodoff P, Corssen G. Pharmacologic Effects of Ci-581, a New Dissociative Anesthetic, in Man. Clin Pharmacol Ther 1965. (6):p. 279-291.
[51] Adamowicz, P. and M. Kala, Urinary excretion rates of ketamine and norketamine following therapeutic ketamine administration: Method and detection window considerations. Journal of Analytical Toxicology, 2005. 29(5): p. 376-382.
[52] Durieux, M.E. and R. Kohrs, Ketamine: Teaching an old drug new tricks. Anesthesia and Analgesia, 1998. 87(5): p. 1186-1193.
[53] Lankenau, S.E. and M.C. Clatts, Ketamine injection among high risk youth: Preliminary findings from New York City. Journal of Drug Issues, 2002. 32(3): p. 893-905.
[54] White PF, Way WL, Trevor AJ: Ketamine Its Pharmacology and therapeuticc uses; Anesthesiology 56:119–136; 1982.
[55] Takeshita H, Okuda Y, Sari A. The effects of ketamine on cerebral circulation and metabolism in man. Anesthesiology, 1972.36 (1):p. 69-75.
[56] Harris JE, Letson RD, Buckley JJ. The use of CI-581, a new parenteral anesthetic, in ophthalmic practice. Trans Am Ophthalmol Soc 1968. 66:p. 206-213.
[57] Idvall J, Ahlgren I, Aronsen KR, Stenberg P. Ketamine infusions: pharmacokinetics and clinical effects. Br J Anaesth 1979.51(12):p. 1167-1173.
|